SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $686,472 | +1.6% | 5,663 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $675,439 | -27.1% | 5,898 | -12.3% | 0.00% | -25.0% |
| Q1 2023 | $926,769 | +20.4% | 6,724 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $769,835 | +83.7% | 5,941 | +56.8% | 0.00% | +100.0% |
| Q3 2022 | $419,000 | +61.2% | 3,788 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -3.0% | 3,471 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $268,000 | -11.3% | 3,427 | +2.3% | 0.00% | 0.0% |
| Q4 2021 | $302,000 | -45.4% | 3,350 | -44.0% | 0.00% | -60.0% |
| Q3 2021 | $553,000 | +7.2% | 5,977 | -10.0% | 0.01% | 0.0% |
| Q2 2021 | $516,000 | +2.6% | 6,642 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $503,000 | -57.2% | 6,743 | -2.1% | 0.01% | -68.8% |
| Q4 2020 | $1,174,000 | +19.3% | 6,885 | -1.0% | 0.02% | 0.0% |
| Q3 2020 | $984,000 | -17.2% | 6,955 | -3.0% | 0.02% | -20.0% |
| Q2 2020 | $1,188,000 | +12.9% | 7,170 | -36.6% | 0.02% | -13.0% |
| Q1 2020 | $1,052,000 | -32.5% | 11,315 | -6.3% | 0.02% | -8.0% |
| Q4 2019 | $1,559,000 | – | 12,080 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |